• Saturday, Nov 28, 2020
  • Last Update : 02:47 am

Acme Lab enters US market with Zolpidem tablet

  • Published at 09:23 pm October 15th, 2020
Acme Laboratories

The publicly traded company said that exploring the US market had been one of Acme's most ambitious projects, which will generate yearly earnings of $50,000 approximately

The Acme Laboratories Limited, a local pharmaceutical company, on Thursday announced that they launched Zolpidem, a tablet used to treat sleep disorder, in the US market through contact manufacturing.

The publicly traded company said that exploring the US market had been one of Acme's most ambitious projects, which will generate yearly earnings of $50,000 approximately.

According to an official disclosure posted on the Dhaka Stock Exchange (DSE) website on the day, the Zolpidem tablets are sold in 5mg. and 10mg doses.

Meanwhile, Acme Laboratories' board of directors had recommended a 25% cash dividend for the year ended on June 30, 2020.

The annual general meeting will be held on December 10 at 11:30am through a digital platform. The record date is November 10.

The company has also reported earnings per share (EPS) of Tk6.85, net asset value (NAV) per share of Tk90 and NOCFPS of Tk5.42 for the year ended on June 30, 2020 as against Tk6.81, Tk86.69 and Tk7.81 respectively for the same period of the previous year.

It is presently an 'A' category company, and was listed on the country's bourses in 2016.

The share price of Acme Laboratories closed at Tk 69.40 each on the DSE on Thursday. The company’s paid-up capital is Tk211 crore.

The Acme Laboratories are currently producing more than 500 products in different dosage forms covering broader therapeutic categories which include anti-infective, cardiovascular, anti-diabetics, gastrointestinal, CNS, respiratory disease etc. among many others.

The sponsor-directors own 41.54% stake in the company, institutional investors 31.45%, foreign investors 0.13% and the general public 26.87% as of July 31, 2020.

51
50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail